| 产品详情 |
| Edit |   |
|---|
| Product Name | NAGLU, Recombinant, Human |
|---|
| Description | Purity ~95% by SDS-PAGE under reducing conditionsEndotoxin: ≤1EU/1ug (LAL). Human lysosomal A-N-acetylglucosaminidase is a hydrolase that catalyses the removal of terminal A-N-acetylglucosamine residues from heparan sulfate and heparin. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. Mucopolysaccharidosis types IIIA, C, and D are caused by mutations in other genes involved in the lysosomal degradation of heparan sulfate. Continuous lysosomal accumulation of heparan sulfate results in the clinical onset of disease, which is typified by severe central nervous system degeneration. Mucopolysaccharidosis type III differs from other mucopolysaccharidoses in that patients usually exhibit mild somatic changes with minimal skeletal abnormalities. Recombinant protein corresponding to Met1-Trp743 from human NAGLU fused to 6-His-tag at C-terminal expressed in CHO cell line. UniProt Accession: P54802. Molecular Weight: ~81kD Sp |
|---|
| Size | 20ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | NAGLU, Recombinant, Human (Alpha-N-acetylglucosaminidase, N-acetyl-alpha-glucosaminidase, NAG, UFHSD1) |
|---|
| Gene, Accession, CAS # | Gene ID: 4669, SwissProt: P54802 |
|---|
| Catalog # | N0017-06 |
|---|
| Price | |
|---|
| Order / More Info | NAGLU, Recombinant, Human from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|